Wolverine Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.26M | Buy |
103,200
+39,100
| +61% | +$2.28M | 0.06% | 282 |
|
|
2025
Q4 | $3.46M | Buy |
+64,100
| New | +$3.08M | 0.03% | 443 |
|
|
2025
Q3 | – | Sell |
-9,500
| Closed | -$440K | – | 1628 |
|
|
2025
Q2 | $440K | Sell |
9,500
-13,900
| -59% | -$682K | ﹤0.01% | 901 |
|
|
2025
Q1 | $1.43M | Sell |
23,400
-25,200
| -52% | -$1.47M | 0.02% | 599 |
|
|
2024
Q4 | $2.75M | Buy |
48,600
+2,100
| +5% | +$117K | 0.03% | 449 |
|
|
2024
Q3 | $2.41M | Sell |
46,500
-35,100
| -43% | -$1.65M | 0.03% | 472 |
|
|
2024
Q2 | $3.39M | Sell |
81,600
-10,200
| -11% | -$456K | 0.04% | 370 |
|
|
2024
Q1 | $4.98M | Sell |
91,800
-27,500
| -23% | -$1.4M | 0.06% | 288 |
|
|
2023
Q4 | $6.12M | Buy |
119,300
+67,400
| +130% | +$3.54M | 0.05% | 314 |
|
|
2023
Q3 | $3.01M | Sell |
51,900
-28,100
| -35% | -$1.72M | 0.03% | 435 |
|
|
2023
Q2 | $5.12M | Buy |
80,000
+3,300
| +4% | +$221K | 0.06% | 291 |
|
|
2023
Q1 | $5.32M | Buy |
76,700
+43,800
| +133% | +$3.09M | 0.06% | 313 |
|
|
2022
Q4 | $2.37M | Buy |
32,900
+32,800
| +32,800% | +$2.47M | 0.02% | 528 |
|
|
2022
Q3 | $7K | Buy |
+100
| New | +$7.25K | ﹤0.01% | 2081 |
|
|
2019
Q2 | – | Sell |
-50,000
| Closed | -$2.38M | – | 1406 |
|
|
2019
Q1 | $2.38M | Sell |
50,000
-53,300
| -52% | -$2.66M | 0.03% | 376 |
|
|
2018
Q4 | $5.37M | Sell |
103,300
-82,700
| -44% | -$4.44M | 0.06% | 275 |
|
|
2018
Q3 | $11.5M | Sell |
186,000
-28,100
| -13% | -$1.67M | 0.13% | 158 |
|
|
2018
Q2 | $11.8M | Buy |
214,100
+108,100
| +102% | +$5.84M | 0.15% | 140 |
|
|
2018
Q1 | $6.7M | Sell |
106,000
-31,800
| -23% | -$2.05M | 0.09% | 213 |
|
|
2017
Q4 | $8.44M | Buy |
137,800
+500
| +0.4% | +$31.3K | 0.09% | 202 |
|
|
2017
Q3 | $8.75M | Buy |
137,300
+24,200
| +21% | +$1.41M | 0.1% | 169 |
|
|
2017
Q2 | $6.3M | Sell |
113,100
-6,600
| -6% | -$359K | 0.08% | 205 |
|
|
2017
Q1 | $6.51M | Buy |
+119,700
| New | +$6.57M | 0.1% | 189 |
|
|
2015
Q4 | – | Sell |
-191
| Closed | -$111K | – | 1702 |
|
|
2015
Q3 | $111K | Buy |
191
+116
| +155% | +$7.36K | ﹤0.01% | 1063 |
|
|
2015
Q2 | $91K | Buy |
75
+60
| +400% | +$3.95K | ﹤0.01% | 1152 |
|
|
2015
Q1 | $29K | Sell |
15
-12
| -44% | -$751 | ﹤0.01% | 1367 |
|
|
2014
Q4 | $24K | Sell |
27
-348
| -93% | -$19.6K | ﹤0.01% | 1581 |
|
|
2014
Q3 | $144K | Sell |
375
-138
| -27% | -$6.89K | ﹤0.01% | 1184 |
|
|
2014
Q2 | $244K | Buy |
513
+376
| +274% | +$18.5K | 0.01% | 850 |
|
|
2014
Q1 | $101K | Buy |
137
+50
| +57% | +$2.66K | ﹤0.01% | 1117 |
|
|
2013
Q4 | $109K | Sell |
87
-88
| -50% | -$4.48K | ﹤0.01% | 1409 |
|
|
2013
Q3 | $139K | Sell |
175
-352
| -67% | -$15.5K | ﹤0.01% | 1315 |
|
|
2013
Q2 | $292K | Buy |
+527
| New | +$22.9K | 0.01% | 958 |
|
Other funds holding BMY
VCM
VPM
Wolverine Asset Management's BMY Position: Q4 2025 in Review
Wolverine Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 220 shares — an estimated $10.6K sold.
Wolverine Asset Management first reported a position in BMY in Q2 2013 and held it in 24 quarters. The position peaked at $15.2M in Q4 2018. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Wolverine Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Wolverine Asset Management sold 220 Bristol-Myers Squibb shares in Q4 2025, an estimated $10.6K.
- Wolverine Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 24 quarters.
- Wolverine Asset Management's Bristol-Myers Squibb position peaked at $15.2M in Q4 2018.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.